Medica Group Plc (LSE:MGP) announces that Dr Stuart Quin has been appointed as Chief Executive Officer. Dr...
Up to date
Appointments
Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies...
Medica Group Plc (LSE:MGP) announces that Jo Easton has been appointed to the Group’s Board of Directors as a...
IGEM Therapeutics, an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat...
Metrion Biosciences today announced the appointment of Dr Andrew Southan as Chief Executive Officer, with...
Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T-cell enhancing therapeutics,...